RARE ALERT: Nestle said to ... - Part 3

It took a while but I see Swiss publication Inside Paradeplatz has finally followed up little old Betaville's RARE Alerts from last year about Nestle's attempt to acquire Seres Therapeutics, the US-listed microbiome biopharmaceutical company.